<body><a name="drugname"></a><table class="topbox" width="100%">
<tr>
<td><span class="topboxgenname">MEQUINOL/TRETINOIN</span><br/>(me-qui'nol/tre-ti'noyn)<br/><span class="topboxtradename">Solagé<br/></span><b>Classifications:</b> <span class="classification">skin and mucous membrane agent</span>; <span class="classification">retinoid</span><br/><b>Prototype: </b>Isotretinoin<br/><b>Pregnancy Category: </b>X<br/></td>
</tr>
</table>
<h1><a name="avail">Availability</a></h1>
<p>Mequinol 2%/tretinoin 0.01% 30 mL solution</p>
<h1><a name="action">Actions</a></h1>
<p>Mequinol is a depigmenting agent and tretinoin is a retinoid used to improve dermatologic changes (e.g., fine wrinkling, mottled
         hyperpigmentation, roughness) associated with photo-damage and aging. Sun avoidance, as well as a comprehensive skin care
         plan (e.g., emollient creams, sunscreen, protective clothing), is very important in controlling age spots.
      </p>
<h1><a name="therapef">Therapeutic Effects</a></h1>
<p>Mequinol's mechanism of depigmentation is probably due to oxidation by tyrosine to cytotoxic products in metanocytes, and/or
         inhibition of melanin formation. Tretinoin, a retinoid, is used to improve photo-damage to the skin by acting via retinoic
         acid receptors (RARs).
      </p>
<h1><a name="uses">Uses</a></h1>
<p>Treatment of solar lentigines.</p>
<h1><a name="contrain">Contraindications</a></h1>
<p>Pregnancy (category X), lactation, hypersensitivity to mequinol, tretinoin.</p>
<h1><a name="precaution">Cautious Use</a></h1>
<p>History of hypersensitivity to acitretin, isotretinoin, etretinate, or other vitamin A derivatives, or hydroquinone; patients
         with eczema, moderate to severe skin pigmentation, vitiligo; concurrent use of photosensitive medications (e.g., thiazide
         diuretics, fluoroquinolones, phenothiazines, sulfonamides), concurrent use of astringents; cold weather.
      </p>
<h1><a name="rtedsg">Route &amp; Dosage</a></h1>
<table cellpadding="4" cellspacing="0" class="rdbox" width="100%">
<tr>
<td><span class="indicationtitle">Solar Lentigines</span><br/><span class="rdage">Adult:</span> <span class="rdroute">Topical</span> Apply to solar lentigines b.i.d. at least 8 h apart<br/></td>
</tr>
</table>
<h1><a name="admintn">Administration</a></h1><span class="adminroutetype">Topical</span><br/><ul>
<li>Apply doses at least 8 h apart; avoid application to unaffected areas.</li>
<li>Avoid contact with eyes, lips, mucus membranes, or paranasal creases.</li>
<li>Protect from light.</li>
</ul>
<h1><a name="adverse">Adverse Effects (<img src="../images/special/greaterorequal.gif"/>1%)</a></h1><span class="typehead">Skin:</span> <span class="speceff-common">Erythema, burning, stinging, tingling, desquamation, pruritus,</span> skin irritation, temporary hypopigmentation, rash, dry skin, crusting, application site reaction. 
      <h1><a name="interactions">Interactions</a></h1><span class="typehead">Drug:</span> <span class="classification">thiazide diuretics</span>, <span class="classification">tetracyclines</span>, <span class="classification">fluoroquinolones</span>, <span class="classification">phenothiazines</span>, <span class="classification">sulfonamides</span> may augment phototoxicity. 
      <h1><a name="pharmaks">Pharmacokinetics</a></h1><span class="typehead">Absorption:</span> 4.4% absorbed through skin. <span class="typehead">Peak:</span> 12 h. 
      <h1><a name="nursing"><span class="implictitle">Nursing Implications</span></a></h1>
<p><span class="adeffecttitle">Assessment &amp; Drug Effects</span></p>
<ul>
<li>Monitor for and report peeling, erythema, or hypopigmentation.</li>
<li>Monitor for signs of tretinoin toxicity: headache, fever, weakness, and fatigue.</li>
</ul>
<p><span class="eductitle">Patient &amp; Family Education</span></p>
<ul>
<li>Do not apply larger than recommended amounts.</li>
<li>Do not wash affected area for at least 6 h after drug application; do not apply cosmetics to affected area for at least 30
            min after drug application.
         </li>
<li>Minimize exposure to sunlight or sunlamps. Use extra caution if also taking concurrently other drugs that are photosensitizing
            (e.g., thiazide diuretics, phenothiazines).
         </li>
<li>Notify physician if vitiligo (hypopigmentation of skin) or S&amp;S of tretinoin toxicity develop (see <small>ASSESSMENT &amp; DRUG EFFECTS</small>).
         </li>
<li>Do not breast feed while taking this drug.</li>
</ul>
<hr/>
<p><span class="footer">Common adverse effects in <i>italic</i>, life-threatening effects <u>underlined</u>; generic names in <b>bold</b>; classifications in <small>SMALL CAPS</small>; <img border="0" src="../images/maple.gif"/> Canadian drug name; <img border="0" src="../images/pr.gif"/> Prototype drug</span></p>
</body>